News Daily News Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients Michael O'Riordan October 26, 2017
News Daily News Secondary Prevention Lagging Behind in Women With Established Coronary Disease Todd Neale September 22, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint Michael O'Riordan February 03, 2017
News Features Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter Michael O'Riordan January 10, 2017